Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants
Disclosure of pathogenic variants to thoracic aortic dissection biobank participants was implemented. The impact and costs, including confirmatory genetic testing in a Clinical Laboratory Improvement Amendment...